Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
US$0,00040
0,00%
(0,00) 1D
13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
12,88 ພັນ
Avg. vol.
18,83 ພັນ
Volume
4,30 ພັນ
52-wk high
US$0,02
52-wk low
US$0,00
Beta
1,66
Shares outstanding
26,83 ລ້ານ
No. of employees
68
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
12,88 ພັນ
Avg. vol.
18,83 ພັນ
Volume
4,30 ພັນ
52-wk high
US$0,02
52-wk low
US$0,00
Beta
1,66
Shares outstanding
26,83 ລ້ານ
No. of employees
68
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
SectorBiotechnology
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ທ.ວ. 2023
ມ.ນ. 2024
ມິ.ຖ. 2024
ກ.ຍ. 2024
Revenue
386,00 ພັນ
-
-
-
Cost of goods sold
-
-
-
20,53 ລ້ານ
Cost of revenue
-
-
-
20,53 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,66 ລ້ານ
Operating expense
-
-
-
5,66 ລ້ານ
Total operating expenses
-
-
-
26,18 ລ້ານ
Operating income
-
-
-
-26,18 ລ້ານ
Other non operating income
-
-
-
20,30 ລ້ານ
EBT including unusual items
-
-
-
-6,40 ລ້ານ
EBT excluding unusual items
-
-
-
-6,40 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,40 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-2,22
-0,10
-0,59
-0,16
Interest and investment income
-
-
-
793,00 ພັນ
Interest expense
-
-
-
-1,31 ລ້ານ
Net interest expenses
-
-
-
-519,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-25,86 ລ້ານ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google